EMPATIQ 10 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 90
Presentation · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brazil
-
Registration number
1003302340041 -
GGREM
523726090056607 -
Barcode
7896094212381
What the source publishes
- Holder
- LIBBS FARMACÊUTICA LTDA
- Active ingredients
- EMPAGLIFLOZINA
- Package
- 10 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 90
- Supply regime
- Tarja Vermelha
- Product type
- Similar
- Therapeutic class
- A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "EMPATIQ 10 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 90",
"holder": "LIBBS FARMACÊUTICA LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896094212381"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "523726090056607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "61.230.314/0001-75",
"priceRegime": "Regulado",
"productName": "EMPATIQ",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "10 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 90",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "595.80",
"icms-12": "677.05",
"icms-17": "717.83",
"icms-18": "726.59",
"icms-19": "735.56",
"icms-20": "744.75",
"icms-21": "754.18",
"icms-22": "763.85",
"icms-23": "773.77",
"icms-17.5": "722.18",
"icms-19.5": "740.12",
"icms-20.5": "749.43",
"icms-22.5": "768.77",
"icms-12-alc": "604.51",
"icms-17-alc": "640.92",
"icms-18-alc": "648.74",
"icms-19-alc": "656.75",
"icms-20-alc": "664.96",
"icms-21-alc": "673.37",
"icms-22-alc": "682.01",
"icms-23-alc": "690.86",
"withoutTaxes": "531.96",
"icms-17.5-alc": "644.81",
"icms-19.5-alc": "660.83",
"icms-20.5-alc": "669.14",
"icms-22.5-alc": "686.41"
},
"pisCofinsList": "Negativa",
"substanceText": "EMPAGLIFLOZINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "799.24",
"icms-12": "908.24",
"icms-17": "962.94",
"icms-18": "974.69",
"icms-19": "986.73",
"icms-20": "999.06",
"icms-21": "1011.71",
"icms-22": "1024.68",
"icms-23": "1037.98",
"icms-17.5": "968.78",
"icms-19.5": "992.84",
"icms-20.5": "1005.33",
"icms-22.5": "1031.28",
"icms-12-alc": "835.70",
"icms-17-alc": "886.03",
"icms-18-alc": "896.84",
"icms-19-alc": "907.92",
"icms-20-alc": "919.27",
"icms-21-alc": "930.89",
"icms-22-alc": "942.84",
"icms-23-alc": "955.07",
"withoutTaxes": "735.41",
"icms-17.5-alc": "891.41",
"icms-19.5-alc": "913.56",
"icms-20.5-alc": "925.05",
"icms-22.5-alc": "948.92"
},
"invalidBarcodes": [],
"activeSubstances": [
"EMPAGLIFLOZINA"
],
"therapeuticClass": "A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1003302340041",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10P1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:523726090056607"